日本高潮视频在线观看-亚洲中文字幕永不卡-精品亚洲一区二区三区-伦理片夜夜躁狠狠躁日日躁-日本最新免费不卡二区-国产精品口爆一区二区三区-av一区二区三区高清-大鸡巴疯狂抽插小穴视频-日韩中文国产在线观看免费视频

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Sulfolobus solfataricus GTP cyclohydrolase III (gch3) CSB-YP836509FPM
CSB-EP836509FPM
CSB-BP836509FPM
CSB-MP836509FPM
CSB-EP836509FPM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Sulfolobus solfataricus Translation initiation factor 6 (eif6) CSB-YP836510FPM
CSB-EP836510FPM
CSB-BP836510FPM
CSB-MP836510FPM
CSB-EP836510FPM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Sulfolobus solfataricus 3-dehydroquinate synthase (aroB) CSB-YP836511FPM
CSB-EP836511FPM
CSB-BP836511FPM
CSB-MP836511FPM
CSB-EP836511FPM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Sulfolobus solfataricus tRNA (cytidine (56)-2'-O)-methyltransferase (SSO0267) CSB-YP836512FPM
CSB-EP836512FPM
CSB-BP836512FPM
CSB-MP836512FPM
CSB-EP836512FPM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Sulfolobus solfataricus 50S ribosomal protein L24e (rpl24e) CSB-YP836513FPM
CSB-EP836513FPM
CSB-BP836513FPM
CSB-MP836513FPM
CSB-EP836513FPM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Sulfolobus solfataricus Uncharacterized N-acetyltransferase SSO0209 (SSO0209) CSB-YP836514FPM
CSB-EP836514FPM
CSB-BP836514FPM
CSB-MP836514FPM
CSB-EP836514FPM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Sulfolobus solfataricus Flap endonuclease 1 (fen) CSB-YP836515FPM
CSB-EP836515FPM
CSB-BP836515FPM
CSB-MP836515FPM
CSB-EP836515FPM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Sulfolobus solfataricus Tritrans,polycis-undecaprenyl-diphosphate synthase (GGDP specific) (uppS) CSB-YP836516FPM
CSB-EP836516FPM
CSB-BP836516FPM
CSB-MP836516FPM
CSB-EP836516FPM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Human herpesvirus 8 type P Viral macrophage inflammatory protein 2 (ORF K4) CSB-YP836517HKE
CSB-EP836517HKE
CSB-BP836517HKE
CSB-MP836517HKE
CSB-EP836517HKE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhizobium loti Alanine racemase 3 (alr3) CSB-YP836518RCU
CSB-EP836518RCU
CSB-BP836518RCU
CSB-MP836518RCU
CSB-EP836518RCU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Molluscum contagiosum virus subtype 1 Glutathione peroxidase (GPX1) CSB-YP836519MHI
CSB-EP836519MHI
CSB-BP836519MHI
CSB-MP836519MHI
CSB-EP836519MHI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhizobium loti 30S ribosomal protein S9 (rpsI) CSB-YP836520RCU
CSB-EP836520RCU
CSB-BP836520RCU
CSB-MP836520RCU
CSB-EP836520RCU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhizobium loti K (+)-insensitive pyrophosphate-energized proton pump (hppA), partial CSB-YP836521RCU
CSB-EP836521RCU
CSB-BP836521RCU
CSB-MP836521RCU
CSB-EP836521RCU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhizobium loti Beta- (1-->2)glucan export ATP-binding/permease protein NdvA (ndvA), partial CSB-YP836522RCU1
CSB-EP836522RCU1
CSB-BP836522RCU1
CSB-MP836522RCU1
CSB-EP836522RCU1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhizobium loti Elongation factor P 2 (efp2) CSB-YP836523RCU
CSB-EP836523RCU
CSB-BP836523RCU
CSB-MP836523RCU
CSB-EP836523RCU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhizobium loti Nucleoside diphosphate kinase (ndk) CSB-YP836524RCU
CSB-EP836524RCU
CSB-BP836524RCU
CSB-MP836524RCU
CSB-EP836524RCU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhizobium loti 30S ribosomal protein S6 (rpsF) CSB-YP836525RCU
CSB-EP836525RCU
CSB-BP836525RCU
CSB-MP836525RCU
CSB-EP836525RCU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhizobium loti GTPase Era (era) CSB-YP836526RCU
CSB-EP836526RCU
CSB-BP836526RCU
CSB-MP836526RCU
CSB-EP836526RCU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhizobium loti Cytochrome c-type biogenesis protein CcmE (ccmE), partial CSB-YP836527RCU
CSB-EP836527RCU
CSB-BP836527RCU
CSB-MP836527RCU
CSB-EP836527RCU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhizobium loti Sulfate adenylyltransferase subunit 2 (cysD) CSB-YP836528RCU
CSB-EP836528RCU
CSB-BP836528RCU
CSB-MP836528RCU
CSB-EP836528RCU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長度(全長或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://m.bdspa.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>



×